Literature DB >> 11773196

Human bone marrow myeloma cells express RANKL.

Orhan Sezer, Ulrike Heider, Christian Jakob, Jan Eucker, Kurt Possinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11773196     DOI： 10.1200/JCO.2002.20.1.353

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  14 in total

1.  B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo.

Authors:  Yan Li; Gianluca Toraldo; Aimin Li; Xiaoying Yang; Hongying Zhang; Wei-Ping Qian; M Neale Weitzmann
Journal:  Blood       Date:  2007-01-03       Impact factor: 22.113

Review 2.  Multiple Myeloma and Bone: The Fatal Interaction.

Authors:  Silvia Marino; G David Roodman
Journal:  Cold Spring Harb Perspect Med       Date:  2018-08-01       Impact factor: 6.915

3.  Mechanisms of multiple myeloma bone disease.

Authors:  Deborah L Galson; Rebecca Silbermann; G David Roodman
Journal:  Bonekey Rep       Date:  2012-08-01

Review 4.  Tumor-host cell interactions in the bone disease of myeloma.

Authors:  Jessica A Fowler; Claire M Edwards; Peter I Croucher
Journal:  Bone       Date:  2010-07-13       Impact factor: 4.398

5.  Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease.

Authors:  Anjli Kukreja; Soroosh Radfar; Ben-Hua Sun; Karl Insogna; Madhav V Dhodapkar
Journal:  Blood       Date:  2009-08-06       Impact factor: 22.113

6.  Bone marrow metastatic myeloma cells promote osteoclastogenesis through RANKL on endothelial cells.

Authors:  Tomoko Okada; Shingo Akikusa; Hiroaki Okuno; Masato Kodaka
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

7.  Expression of receptor activator of NF-kappaB ligand (RANKL) mRNA in human multiple myeloma cells.

Authors:  Ulrike Heider; Ivana Zavrski; Christian Jakob; Katharina Bängeroth; Claudia Fleissner; Corinna Langelotz; Kurt Possinger; Lorenz C Hofbauer; Volker Viereck; Orhan Sezer
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-15       Impact factor: 4.553

8.  Integrated cellular bone homeostasis model for denosumab pharmacodynamics in multiple myeloma patients.

Authors:  Anshu Marathe; Mark C Peterson; Donald E Mager
Journal:  J Pharmacol Exp Ther       Date:  2008-05-06       Impact factor: 4.030

Review 9.  Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

Authors:  Ann E Kearns; Sundeep Khosla; Paul J Kostenuik
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

Review 10.  The role of dendritic cells derived osteoclasts in bone destruction diseases.

Authors:  Bo Wang; Yutong Dong; Zhansong Tian; Yueqi Chen; Shiwu Dong
Journal:  Genes Dis       Date:  2020-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.